CEVA Santé Animale

Global veterinary health company specialized in pharmaceutical products and vaccines

CEVA Santé Animale (“the Company”) develops, manufactures and distributes animal health products. The Company’s main expertise lies within the anti-invectives, vaccines and reproduction control devices areas. At the time of exiting, CEVA operated in all key European markets and established a strong presence in international growing markets such as Eastern and Central Europe, Middle East and Turkey, Africa, Asia, and Latin America. 

The company is headquartered in Libourne near Bordeaux, France.

CEVA was acquired by the IK 2000 Fund from PAI Partners in September 2003. It was then sold in June 2007 to its management, associated with a consortium of investors grouping Euromezzanine, Natexis Industrie and Natixis Investissement.

Our Value Creation Strategy

During our ownership, we worked alongside the management team to:

• Develop companion animal products and vaccines;
• Expand customer-base in North America;
• Pursue add-on acquisitions; and
• Accelerate operational improvements.